(October 18, 2017)
In this talk, we provide a compelling overview of how predictive models are used at various stages of development and manufacturing in the biopharmaceutical industry. Case studies covering a wide range of the biologic product chain from drug substance to drug product and devices are presented, to show how modeling contributes to the scientific advancement, strategic objectives, and bottom line of our technical operations at Biogen. While our main focus is on mainstream applications of CFD modeling in the biopharmaceutical industry, non-traditional uses of CFD and other first-principles modeling techniques will also be presented here. Through this presentation, we intend to provide inspiring perspectives on the value of predictive models and advocate their increased adoption in the Biopharmaceutical industry.
Global Industry Director
As the ANSYS Global Industry Director since 2006, Thierry Marchal leads the medical devices, pharmaceutical and biotech strategy of ANSYS through the in silico and personalized medicine evolution by closely interacting with industrial innovators and SMEs, academic leaders and governmental and regulatory authorities such as the FDA and the EMA. In his 25+ years of professional experience, Thierry has worked as the Global Materials Market Segment Manager with Fluent and Product Manager for Polyflow. Thierry holds a degree in Mechanical Engineering from UCL.